news & events
ysios news
21.07.17
Kala Pharmaceuticals Announces Pricing of Initial Public Offering
30.06.17
Babyscripts Raises $5.7 Million to Build the Market’s Most Robust, Clinically-Validated Virtual Care Women’s Health Platform
23.05.17
Anaconda Biomed Secures 15 Million Euro in Series A Financing Led by Ysios Capital, Innogest Capital and Omega Funds.
04.05.17
Vivet Therapeutics raises €37.5 million in Series A financing round to advance novel gene therapies for treating inherited metabolic diseases
23.03.17
BioClin Therapeutics, Inc., Raises $30 Million in Series B Financing Led by Sofinnova Ventures and Ysios Capital
20.03.17
MedLumics Secures 34.4 Million Euros in Series B Funding
08.02.17
Prexton Therapeutics Series B financing round raises EUR 29 million (USD 31 million) to advance its novel Parkinson’s therapeutic
30.11.16
OxThera raises EUR 32 million to complete development of Oxabact® for treatment of Primary hyperoxaluria
04.11.16
CorWave Raises $17.1 Million in Series B Financing
18.10.16
Ysios capital raises €126,4 m ($140 m) for its second fund, Ysios Biofund II Innvierte
